Observational Pharmaco-Epidemiology Research & Analysis

RecruitingOBSERVATIONAL
Enrollment

2,000,000

Participants

Timeline

Start Date

December 1, 2013

Primary Completion Date

November 30, 2035

Study Completion Date

November 30, 2035

Conditions
Chronic DiseaseHIV/AIDSLiver DiseasesInflammatory Bowel DiseasesCardiovascular DiseasesRheumatic DiseasesNeurodegenerative Diseases
Interventions
OTHER

Non-interventional (observational only)

Trial Locations (1)

27703

RECRUITING

Epividian, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Epividian

INDUSTRY

NCT03813862 - Observational Pharmaco-Epidemiology Research & Analysis | Biotech Hunter | Biotech Hunter